Roche has launched a home self-test Bluetooth device for patients to measure blood clotting status, with results sent straight to the doctor. It will be available in all countries accepting the CE ...

FREMONT, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- CoaguSense, Inc., a subsidiary of i-SENS (KOSDAQ:099190), today announced that it has received approval for the sale of the Coag-Sense ® PT/INR ...

DARESBURY, UNITED KINGDOM--(Marketwired - May 12, 2016) - Bio-AMD, Inc. and Bio-AMD Holdings Ltd., our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company") (OTCQB: ...

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Siemens Healthineers has more than 30 years of central lab hemostasis leadership. Building on to its portfolio, the company announced today FDA 510(k) clearance for a ...

As issues related to potential problems with the device used to monitor warfarin therapy in the ROCKET AF trial continue to be discussed, the US Food and Drug Administration (FDA) is taking a deeper ...

The US Food and Drug Administration (FDA) has concluded that inaccurate results from the point-of-care device used to measure international normalized ratio (INR) values in warfarin-treated patients ...

My doctor has approved use of the Phillips Self Testing PT/INR machine. Medicare will pay 80 percent of the test strip cost. Does TRICARE cover PT/INR self testing? Thank you. Anna G. Via the Internet ...

Roche unveiled a new app for patients on anticoagulation therapy, allowing them to see results from their at-home blood clotting tests on an iOS device. The app connects via Bluetooth to the CoaguChek ...

The microINR system offers distinct advantages such as automatic calibration as well as multilevel quality control and low sample volume MOUNTAIN VIEW, California, Oct. 3, 2016 /PRNewswire/ -- Based ...

The market for home healthcare devices is growing at a steady clip, and Roche ($RHHBY) is wise to the trend. The Swiss diagnostics giant is launching its PT/INR home ...